Science Explorer Back to mapMap
Discussion

Sab Biotherapeutics (United States)

Research works
27
▼ 17% vs 2018-21
Citations
627
23.1 per fractional work
Top-10% rate
5.6%
all institutions 10.0%
Open access
61%
world 40%
International
26%
world 18%

Not ranked overall: Sab Biotherapeutics (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Sab Biotherapeutics (United States) work in?

In all years, 45% of research at Sab Biotherapeutics (United States) is in Health Sciences, 31% in Life Sciences. Its largest fields are Medicine (42%), Biochemistry, Genetics and Molecular Biology (15%), Agricultural and Biological Sciences (9%). It does 1.6× the world's share of Health Sciences.

Health Sciences: 12 fractional works · 45.0% of its workMedicine: 12 fractional works · 42.5% of its workInfectious Diseases: 3 fractional works · 10.8% of its workOncology: 3 fractional works · 9.3% of its workRadiology, Nuclear Medicine and Imaging: 2 fractional works · 7.9% of its workEpidemiology: 1 fractional works · 2.2% of its workHematology: 1 fractional works · 2.0% of its workHepatology: 0 fractional works · 1.4% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 1.4% of its workSurgery: 0 fractional works · 1.3% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.8% of its workGenetics: 0 fractional works · 0.8% of its workImmunology and Allergy: 0 fractional works · 0.7% of its workPathology and Forensic Medicine: 0 fractional works · 0.7% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 0.6% of its workEmergency Medicine: 0 fractional works · 0.6% of its workPulmonary and Respiratory Medicine: 0 fractional works · 0.6% of its workRheumatology: 0 fractional works · 0.6% of its workTransplantation: 0 fractional works · 0.3% of its workNeurology: 0 fractional works · 0.2% of its workPhysiology: 0 fractional works · 0.2% of its workHealth Professions: 0 fractional works · 1.8% of its workGeneral Health Professions: 0 fractional works · 1.8% of its workVeterinary: 0 fractional works · 0.4% of its workSmall Animals: 0 fractional works · 0.4% of its workNursing: 0 fractional works · 0.3% of its workIssues, ethics and legal aspects: 0 fractional works · 0.3% of its workLife Sciences: 8 fractional works · 30.6% of its workBiochemistry, Genetics and Molecular Biology: 4 fractional works · 15.5% of its workMolecular Biology: 2 fractional works · 5.9% of its workGenetics: 1 fractional works · 5.0% of its workBiotechnology: 0 fractional works · 1.6% of its workDevelopmental Biology: 0 fractional works · 1.2% of its workCell Biology: 0 fractional works · 1.0% of its workCancer Research: 0 fractional works · 0.5% of its workEndocrinology: 0 fractional works · 0.3% of its workAgricultural and Biological Sciences: 2 fractional works · 9.2% of its workEcology, Evolution, Behavior and Systematics: 1 fractional works · 4.0% of its workGeneral Agricultural and Biological Sciences: 1 fractional works · 2.5% of its workAnimal Science and Zoology: 0 fractional works · 1.3% of its workPlant Science: 0 fractional works · 1.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workImmunology and Microbiology: 1 fractional works · 5.3% of its workImmunology: 1 fractional works · 5.3% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.6% of its workPharmacology: 0 fractional works · 0.6% of its workPhysical Sciences: 4 fractional works · 16.2% of its workEnvironmental Science: 2 fractional works · 8.6% of its workWater Science and Technology: 1 fractional works · 3.7% of its workEcology: 0 fractional works · 1.8% of its workNature and Landscape Conservation: 0 fractional works · 1.6% of its workGlobal and Planetary Change: 0 fractional works · 1.0% of its workEnvironmental Engineering: 0 fractional works · 0.5% of its workEngineering: 1 fractional works · 4.9% of its workBuilding and Construction: 0 fractional works · 1.2% of its workCivil and Structural Engineering: 0 fractional works · 1.2% of its workMechanical Engineering: 0 fractional works · 1.2% of its workMechanics of Materials: 0 fractional works · 1.2% of its workSmaller subfields together: 0 fractional works · 0.0% of its workMaterials Science: 0 fractional works · 1.2% of its workPolymers and Plastics: 0 fractional works · 1.2% of its workComputer Science: 0 fractional works · 0.8% of its workComputational Theory and Mathematics: 0 fractional works · 0.8% of its workChemistry: 0 fractional works · 0.6% of its workAnalytical Chemistry: 0 fractional works · 0.6% of its workSocial Sciences: 2 fractional works · 8.2% of its workSocial Sciences: 1 fractional works · 4.7% of its workGeneral Social Sciences: 1 fractional works · 3.7% of its workEducation: 0 fractional works · 0.4% of its workPolitical Science and International Relations: 0 fractional works · 0.4% of its workSociology and Political Science: 0 fractional works · 0.3% of its workArts and Humanities: 0 fractional works · 1.6% of its workLiterature and Literary Theory: 0 fractional works · 0.8% of its workHistory: 0 fractional works · 0.4% of its workMusic: 0 fractional works · 0.4% of its workBusiness, Management and Accounting: 0 fractional works · 1.2% of its workStrategy and Management: 0 fractional works · 1.2% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.4% of its workEconomics and Econometrics: 0 fractional works · 0.4% of its workPsychology: 0 fractional works · 0.3% of its workSocial Psychology: 0 fractional works · 0.3% of its workALL ITS WORKSabBiotherapeutics…27fractional works, all years
Life Sciences31%Physical Sciences16%Health Sciences45%Social Sciences8%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 18 fields, with their numbers
    1. Medicine1242.5%
    2. Health Professions01.8%
    3. Veterinary00.4%
    4. Nursing00.3%
    1. Biochemistry, Genetics and Molecular Biology415.5%
    2. Agricultural and Biological Sciences29.2%
    3. Immunology and Microbiology15.3%
    4. Pharmacology, Toxicology and Pharmaceutics00.6%
    1. Environmental Science28.6%
    2. Engineering14.9%
    3. Materials Science01.2%
    4. Computer Science00.8%
    5. Chemistry00.6%
    1. Social Sciences14.7%
    2. Arts and Humanities01.6%
    3. Business, Management and Accounting01.2%
    4. Economics, Econometrics and Finance00.4%
    5. Psychology00.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 2.70× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.35× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 3.94× its world share, 0 worksImmunology and Micro…Chemistry: 1.29× its world share, 0 worksChemistryEnvironmental Science: 0.82× its world share, 0 worksEnvironmental ScienceMedicine: 2.30× its world share, 4 worksMedicineArts and Humanities: 1.87× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 1.26× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 0.54× its world share, 0 worksEconomics, Econometr…Psychology: 0.27× its world share, 0 worksPsychologySocial Sciences: 0.28× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 3.9×. Every wedge is a field page.

All 11 fields, with their numbers
  1. Immunology and Microbiology3.94×0 works
  2. Biochemistry, Genetics and Molecular Biology3.35×2 works
  3. Agricultural and Biological Sciences2.70×1 works
  4. Medicine2.30×4 works
  5. Arts and Humanities1.87×0 works
  6. Chemistry1.29×0 works
  7. Business, Management and Accounting1.26×0 works
  8. Environmental Science0.82×0 works
  9. Economics, Econometrics and Finance0.54×0 works
  10. Social Sciences0.28×0 works
  11. Psychology0.27×0 works

Who are the top researchers at Sab Biotherapeutics (United States)?

Ranked on the quality score, Hua Wu, Jin‐an Jiao and Eddie J. Sullivan lead among researchers whose main affiliation is Sab Biotherapeutics (United States).

  1. 1 Hua Wu United States · #782,663 worldwide 4k citations · 176 works
  2. 2 Jin‐an Jiao United States · #940,903 worldwide 1.9k citations · 62 works
  3. 3 Eddie J. Sullivan United States · #1,262,419 worldwide 1.9k citations · 54 works
  4. 4 Christoph L Bausch United States · #3,607,311 worldwide 957 citations · 31 works
All ranked researchers at Sab Biotherapeutics (United States)

What are the most cited papers from Sab Biotherapeutics (United States)?

The most cited paper from Sab Biotherapeutics (United States) is "Hypothermia for neuroprotection after cardiac arrest: Systematic review and individual patient data meta-analysis" (Michael S. Holzer, Stephen A. Bernard, Saı̈d Hachimi-Idrissi et al., 2005), with 481 citations. Next come "Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a)." (247) and "Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo" (119).

Most cited papers
#PaperReleasedCitations
1 Hypothermia for neuroprotection after cardiac arrest: Systematic review and individual patient data meta-analysis Michael S. Holzer, Stephen A. Bernard, Saı̈d Hachimi-Idrissi et al. · Critical Care Medicine Review Feb 2005 481
2 Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a). MacRae F. Linton, Robert V. Farese, Giulia Chiesa et al. · Journal of Clinical Investigation Open access Dec 1993 247
3 Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo Thomas C Luke et al. · Science Translational Medicine Open access 17 Feb 2016 119
4 Safety and tolerability of a novel, polyclonal human anti-MERS coronavirus antibody produced from transchromosomic cattle: a phase 1 randomised, double-blind, single-dose-escalation study John H Beigel, Jocelyn Voell, Parag Kumar et al. · The Lancet Infectious Diseases Open access 9 Jan 2018 117
5 DNA vaccine–derived human IgG produced in transchromosomal bovines protect in lethal models of hantavirus pulmonary syndrome Jay W. Hooper, Rebecca L. Brocato, Steven A. Kwilas et al. · Science Translational Medicine 26 Nov 2014 74
All 54 most cited papers, with filters and sorting

Which keywords describe research at Sab Biotherapeutics (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Pathogenesis, Vaccine, Epidemiology, Glycosylation, Monoclonal Antibodies, Climate Change, Fc Receptors and Therapeutic Antibodies.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 22 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 22 words, with their numbers
  1. Epidemiology3▲ 3.1×14 topics
  2. Pathogenesis3▲ 19×7 topics
  3. Vaccine2▲ 21×5 topics
  4. Climate Change2▲ 3.0×10 topics
  5. Glycosylation2▲ 34×3 topics
  6. Monoclonal Antibodies2▲ 38×2 topics
  7. Fc Receptors1▲ 50×1 topic
  8. Gene Therapy1▲ 19×3 topics
  9. Therapeutic Antibodies1▲ 39×1 topic
  10. Environmental Impact1▲ 3.7×2 topics
  11. Immune Response1▲ 7.8×7 topics
  12. Immunotherapy1▲ 7.4×3 topics
  13. Cancer1▲ 2.8×5 topics
  14. History1▲ 5.1×2 topics
  15. Sustainability1▲ 2.2×4 topics
  16. Genomic Integration1▲ 37×2 topics
  17. Immunity1▲ 11×3 topics
  18. Medical Education1▲ 16×2 topics
  19. Multivariate Statistical Techniques1▲ 102×1 topic
  20. Philosophy1▲ 8.1×1 topic
  21. Social Sciences1▲ 22×1 topic
  22. Water Quality Index1▲ 102×1 topic

Which research topics does Sab Biotherapeutics (United States) publish most on?

By volume in 2022-now: Monoclonal and Polyclonal Antibodies Research, SARS-CoV-2 and COVID-19 Research, Pancreatic and Hepatic Oncology Research and Cancer Research and Treatments.

  1. 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  2. 2 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
  3. 3 Pancreatic and Hepatic Oncology Research Oncology 0 works
  4. 4 Cancer Research and Treatments Biotechnology 0 works
  5. 5 Agriculture, Land Use, Rural Development General Agricultural and Biological Sciences 0 works
  6. 6 Latin American rural development General Agricultural and Biological Sciences 0 works
  7. 7 Global trade, sustainability, and social impact Strategy and Management 0 works
  8. 8 Nutrition, Genetics, and Disease Genetics 0 works
  9. 9 Virus-based gene therapy research Genetics 0 works
  10. 10 Yersinia bacterium, plague, ectoparasites research Genetics 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available61.1%not open38.9%

World: 40% of research is openly available.

with international co-authors26.0%domestic only74.0%

World: 18% is written across borders.

How has Sab Biotherapeutics (United States)'s research output changed?

Output in 2022-2025 was 17% lower than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Sab Biotherapeutics (United States) as a percentage of every work published that year, 0.000034% in 2024.

still counting0.000050%0.00010%0.00015%Sab Biotherapeutics (United States)0.000039% in 202519801990200020102020

Fractional works of Sab Biotherapeutics (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Sioux Falls

All research institutions in Sioux Falls

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Sab Biotherapeutics (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.